Pulmonx (LUNG) Non-Current Deferred Tax Liability (2019 - 2025)

Pulmonx (LUNG) has 7 years of Non-Current Deferred Tax Liability data on file, last reported at $69000.0 in Q4 2025.

• Non-Current Deferred Tax Liability for Q4 2025 came in at $69000.0, down 20.69% year-over-year; the trailing twelve-month figure through Dec 2025 was $69000.0 (down 20.69% YoY), and the FY2025 annual result was $69000.0, down 20.69% from the prior year.
• Non-Current Deferred Tax Liability advanced to $69000.0 in Q4 2025 per LUNG's latest filing, from $47000.0 in the prior quarter.
• Over five years, Non-Current Deferred Tax Liability peaked at $140000.0 in Q1 2024 and troughed at $37000.0 in Q4 2021.
• A 5-year average of $79000.0 and a median of $71000.0 in 2021 frame the typical range for Non-Current Deferred Tax Liability.
• The sharpest annual moves came in 2022 and 2025: Non-Current Deferred Tax Liability soared 154.05% in 2022, then tumbled 65.25% in 2025.
• A 5-year view of Non-Current Deferred Tax Liability shows it stood at $37000.0 in 2021, then jumped by 154.05% to $94000.0 in 2022, then rose by 21.28% to $114000.0 in 2023, then fell by 23.68% to $87000.0 in 2024, then dropped by 20.69% to $69000.0 in 2025.
• Business Quant data shows LUNG's Non-Current Deferred Tax Liability at $69000.0 in Q4 2025, $47000.0 in Q3 2025, and $41000.0 in Q2 2025.